Skip to Content

Rockefeller Capital Management L.P. sells 7,119 Becton, Dickinson and Company shares (NYSE:BDX)

Rockefeller Capital Management L.P. sells 7,119 Becton, Dickinson and Company shares (NYSE:BDX)

According to the most recent Form 13F filing that Rockefeller Capital Management L.P. made with the Securities and Exchange Commission (SEC), the Company’s interest in Becton, Dickinson, and Company (NYSE: BDX) decreased by 1.6% in the third quarter. Rockefeller Capital Management L.P. provided this information. The Company ended the quarter with 448,328 shares of the medical equipment supplier’s stock after selling 7,119 shares. According to the most recent report that Rockefeller Capital Management L.P. submitted to the Securities and Exchange Commission, the firm owned approximately 0.16% of Becton, Dickinson, and the value of its stake was approximately $99,900,000. (SEC).

A significant number of other hedge funds have, in a manner analogous to that taken by the corporation, decreased the proportion of its holdings within their portfolios. In the second quarter, Tranquilli Financial Advisor LLC added 4.8% more Becton Dickinson stock to its holdings, resulting in the Company’s holdings comprising a greater percentage of its total assets. After making an additional purchase of 42 shares during the relevant period, Tranquilli Financial Advisor LLC now owns 912 shares of the medical equipment supplier’s stock, which is $225,000. This brings the total number of shares owned by the Company to a cumulative total of 912. During the second quarter, Capital Asset Advisory Services LLC achieved a 3.1% increase in the proportion of Becton, Dickinson stock it owned. Capital Asset Advisory Services LLC now has a total of 1,433 shares of the Company’s stock, which has a market value of $353,000 after making an additional purchase of 43 shares during the period in question. This brings the total number of shares owned by the Company to 1,433. Physicians Financial Services Inc. increased the amount of Becton, Dickinson, and Company stock that is owned by one-hundredth of one percent during the third quarter. Physicians Financial Services Inc. now has 4,517 shares of the medical equipment supplier’s stock, worth a combined total of $1,007,000 after purchasing an additional 46 shares during the period in question. This brings the Company’s total number of shares to 4,617. Naples Global Advisors LLC increased the amount of Becton, Dickinson stock that it held by 4.4% during the year’s second quarter. Naples Global Advisors LLC now has 1,180 shares of the medical instrument supplier’s stock after purchasing an additional 50 shares. The Company’s stock is currently valued at $291,000 due to the 1,180 shares it owns. Finally, during the second quarter, Congress Wealth Management LLC DE increased its holdings in Becton, Dickinson, by a percentage equal to 4% of the total value of those holdings. Congress Wealth Management LLC DE now holds 1,286 shares of the Company’s stock after purchasing an additional 50 shares during the preceding quarter. This amounts to a market capitalization of $317,000 for the Company. At the moment, institutions own 87.08 percent of the equity in the Company.

The price of BDX shares increased by $0.81 during the trading session on Tuesday, bringing the total cost of those shares to $256.66. There were 21,440 transactions involving the stock, with an average volume of 875,027 shares trading hands. The market capitalization of the Company is currently at $72.96 billion, and its key indicators include the following:

A price-to-earnings ratio of 43.58.

A price-to-growth ratio of 2.25.

A beta value of 0.58.

In addition, the Company has a beta value of 0.58. Over the past year, Becton, Dickinson, and Company prices have ranged from $215.90 to $280.62 at the extremes. The moving average price of the share of stock over the past 50 days is $245.29, while the moving average price over the past 200 days is $243.72. The debt-to-equity ratio, the current ratio, and the quick ratio equal 0.63. This indicates that the Company is in a stable financial position. The current and quick ratios are at 1.04, while the quick ratios are at 0.63.

The most recent quarterly earnings report for Becton, Dickinson, and Company, traded on the New York Stock Exchange under the symbol BDX, was released on November 10. The medical equipment manufacturer reported $2.75 per share earnings for the quarter, which is $0.02 more than the consensus estimate of $2.73 per share. This news came as a surprise to the market. The revenue for the quarter came in at $4.76 billion, which was significantly higher than the prediction for that metric, which was $4.72 billion on average. Becton, Dickinson, and Company had a very successful year, as shown by the high return on equity of 14.47% and the low net margin of 9.16% they achieved. The Company’s revenue dropped by 6.6% when measured against the numbers for the same quarter in the prior year. In the same period the year before, the Company reported $2.15 per share earnings. According to the projections made by market analysts, Becton, Dickinson, and Company are expected to generate earnings of 11.93 cents per share during the current fiscal year.

In addition, the Company announced the payment of a quarterly dividend, which was disbursed the next day, on December 30. On Friday, December 9, dividend payments were sent out to stockholders whose information was already on file. The amount of each dividend payment was $0.91 per share. As of December 8, it was considered that this dividend had been paid out in its entirety.

Tags

Leave a comment

Your email address will not be published. Required fields are marked *